Serotonin syndrome and other serotonergic disorders

被引:107
作者
Ener, RA
Meglathery, SB
Decker, WAV
Gallagher, RM
机构
[1] MCP Hahnemann Univ Hosp, Philadelphia, PA 19102 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
关键词
serotonin syndrome; neuroleptic malignant syndrome (NMS); akathisia; tardive dyskinesia; parkinson's disease; selective serotonin reuptake inhibitors (SSRI); neuroleptics;
D O I
10.1046/j.1526-4637.2003.03005.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Serotonin syndrome is an iatrogenic disorder induced by pharmacologic treatment with serotonergic agents that increases serotonin activity. In addition, there is a wide variety of clinical disorders associated with serotonin excess. The frequent concurrent use of serotonergic and neuroleptic drugs and similarities between serotonin syndrome and neuroleptic malignant syndrome can present the clinician with a diagnostic challenge. In this article, we review the pathophysiology, diagnosis, and treatment of serotonin syndrome as well as other serotonergic disorders.
引用
收藏
页码:63 / 74
页数:12
相关论文
共 53 条
[1]   Nonfunctional CYP2D6 alleles and risk for neuroleptics-induced movement disorders in schizophrenic patients [J].
Andreassen, OA ;
MacEwan, T ;
Gulbrandsen, AK ;
McCreadie, RG ;
Steen, VM .
PSYCHOPHARMACOLOGY, 1997, 131 (02) :174-179
[2]   MUTANT DEBRISOQUINE HYDROXYLATION GENES IN PARKINSONS-DISEASE [J].
ARMSTRONG, M ;
DALY, AK ;
CHOLERTON, S ;
BATEMAN, DN ;
IDLE, JR .
LANCET, 1992, 339 (8800) :1017-1018
[3]   Antipsychotic drug-Induced movement disorders in schizophrenics in relation to CYP2D6 genotype [J].
Armstrong, M ;
Daly, AK ;
Blennerhassett, R ;
Ferrier, N ;
Idle, JR .
BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 :23-26
[4]   POLYMORPHIC DRUG-METABOLISM IN SCHIZOPHRENIC-PATIENTS WITH TARDIVE-DYSKINESIA [J].
ARTHUR, H ;
DAHL, ML ;
SIWERS, B ;
SJOQVIST, F .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (03) :211-216
[5]  
BLACK B, 1992, J CLIN PSYCHIAT, V53, P327
[6]   SEROTONIN SYNDROME [J].
BODNER, RA ;
LYNCH, T ;
LEWIS, L ;
KAHN, D .
NEUROLOGY, 1995, 45 (02) :219-223
[7]  
BOUCHARD RH, 1989, AM J PSYCHIAT, V146, P1352
[8]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[9]   INHIBITION BY PAROXETINE OF DESIPRAMINE METABOLISM IN EXTENSIVE BUT NOT IN POOR METABOLIZERS OF SPARTEINE [J].
BROSEN, K ;
HANSEN, JG ;
NIELSEN, KK ;
SINDRUP, SH ;
GRAM, LF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (04) :349-355
[10]   Pathophysiology and management of the serotonin syndrome [J].
Brown, TM ;
Skop, BP ;
Mareth, TR .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) :527-533